Algert Global’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.52M | Buy |
269,488
+55,650
| +26% | +$1.76M | 0.18% | 168 |
|
|
2025
Q1 | $7.1M | Sell |
213,838
-17,070
| -7% | -$567K | 0.18% | 167 |
|
|
2024
Q4 | $7.95M | Buy |
230,908
+139,967
| +154% | +$4.82M | 0.19% | 159 |
|
|
2024
Q3 | $3.64M | Sell |
90,941
-11,670
| -11% | -$467K | 0.1% | 358 |
|
|
2024
Q2 | $3.1M | Sell |
102,611
-25,000
| -20% | -$754K | 0.1% | 325 |
|
|
2024
Q1 | $4.29M | Sell |
127,611
-32,530
| -20% | -$1.09M | 0.17% | 200 |
|
|
2023
Q4 | $5.17M | Buy |
160,141
+124,456
| +349% | +$4.02M | 0.21% | 131 |
|
|
2023
Q3 | $1.17M | Sell |
35,685
-4,730
| -12% | -$155K | 0.06% | 532 |
|
|
2023
Q2 | $1.42M | Buy |
40,415
+26,750
| +196% | +$941K | 0.06% | 520 |
|
|
2023
Q1 | $446K | Sell |
13,665
-3,728
| -21% | -$122K | 0.02% | 856 |
|
|
2022
Q4 | $958K | Buy |
17,393
+2,390
| +16% | +$132K | 0.05% | 587 |
|
|
2022
Q3 | $664K | Sell |
15,003
-282
| -2% | -$12.5K | 0.04% | 717 |
|
|
2022
Q2 | $745K | Sell |
15,285
-9,996
| -40% | -$487K | 0.06% | 600 |
|
|
2022
Q1 | $1.23M | Buy |
+25,281
| New | +$1.23M | 0.08% | 431 |
|